Imported Disease Annotations - OMIMTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Carey-Fineman-Ziter Syndrome 1 | | IAGP | | 7240710 | | OMIM | | |
|
Imported Disease Annotations - OMIMTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Carey-Fineman-Ziter Syndrome 1 | | IAGP | | 7240710 | | OMIM | | |
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:21873635 | PMID:28681861 | PMID:29560417 | PMID:31642939 | PMID:34288723 |
MYMK (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mymk (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mymk (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mymk (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MYMK (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MYMK (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mymk (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MYMK (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MYMK (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mymk (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in MYMK
45 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | See cases [RCV000050348] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:121112395-138075224)x3 | copy number gain | See cases [RCV000051009] | Chr9:121112395..138075224 [GRCh38] Chr9:123874673..140969676 [GRCh37] Chr9:122914494..140089497 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:122792658-138124532)x3 | copy number gain | See cases [RCV000051040] | Chr9:122792658..138124532 [GRCh38] Chr9:125554937..141018984 [GRCh37] Chr9:124594758..140138805 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9q34.2(chr9:133504071-133777922)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052259]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052259]|See cases [RCV000052259] | Chr9:133504071..133777922 [GRCh38] Chr9:136324358..136643044 [GRCh37] Chr9:135314179..135632865 [NCBI36] Chr9:9q34.2 |
uncertain significance |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 | copy number gain | See cases [RCV000053745] | Chr9:193412..138124532 [GRCh38] Chr9:204193..141018984 [GRCh37] Chr9:194193..140138805 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q34.11-34.3(chr9:129068560-136495351)x3 | copy number gain | See cases [RCV000053779] | Chr9:129068560..136495351 [GRCh38] Chr9:131830839..139389803 [GRCh37] Chr9:130870660..138509624 [NCBI36] Chr9:9q34.11-34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 | copy number gain | See cases [RCV000053746] | Chr9:193412..138114463 [GRCh38] Chr9:214367..141008915 [GRCh37] Chr9:204367..140128736 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] | Chr9:193412..138179445 [GRCh38] Chr9:266045..141073897 [GRCh37] Chr9:256045..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q34.13-34.2(chr9:131406683-133852779)x4 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053812]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053812]|See cases [RCV000053812] | Chr9:131406683..133852779 [GRCh38] Chr9:134282070..136717901 [GRCh37] Chr9:133271891..135707722 [NCBI36] Chr9:9q34.13-34.2 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:121586837-138179445)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053776]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053776]|See cases [RCV000053776] | Chr9:121586837..138179445 [GRCh38] Chr9:124349116..141073897 [GRCh37] Chr9:123388937..140193718 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
NM_001080483.2(TMEM8C):c.136-2179C>T | single nucleotide variant | Lung cancer [RCV000108187] | Chr9:133522467 [GRCh38] Chr9:136387589 [GRCh37] Chr9:9q34.2 |
uncertain significance |
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) | copy number gain | See cases [RCV000133791] | Chr9:204193..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q34.11-34.3(chr9:130513207-138124532)x3 | copy number gain | See cases [RCV000133778] | Chr9:130513207..138124532 [GRCh38] Chr9:133388594..141018984 [GRCh37] Chr9:132378415..140138805 [NCBI36] Chr9:9q34.11-34.3 |
pathogenic |
GRCh38/hg38 9q34.11-34.3(chr9:129068560-138179445)x3 | copy number gain | See cases [RCV000134916] | Chr9:129068560..138179445 [GRCh38] Chr9:131830839..141073897 [GRCh37] Chr9:130870660..140193718 [NCBI36] Chr9:9q34.11-34.3 |
pathogenic |
GRCh38/hg38 9q33.2-34.3(chr9:121073102-138179445)x3 | copy number gain | See cases [RCV000134920] | Chr9:121073102..138179445 [GRCh38] Chr9:123835380..141073897 [GRCh37] Chr9:122875201..140193718 [NCBI36] Chr9:9q33.2-34.3 |
pathogenic |
GRCh38/hg38 9q34.13-34.3(chr9:132986903-138114463)x3 | copy number gain | See cases [RCV000136790] | Chr9:132986903..138114463 [GRCh38] Chr9:135862290..141008915 [GRCh37] Chr9:134852111..140128736 [NCBI36] Chr9:9q34.13-34.3 |
pathogenic |
GRCh38/hg38 9q34.2-34.3(chr9:133504071-138159073)x3 | copy number gain | See cases [RCV000137825] | Chr9:133504071..138159073 [GRCh38] Chr9:136324358..141053525 [GRCh37] Chr9:135314179..140173346 [NCBI36] Chr9:9q34.2-34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 | copy number gain | See cases [RCV000138783] | Chr9:193412..138124524 [GRCh38] Chr9:204090..141018976 [GRCh37] Chr9:194090..140138797 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000139207] | Chr9:193412..138159073 [GRCh38] Chr9:68420641..141053525 [GRCh37] Chr9:67910461..140173346 [NCBI36] Chr9:9p11.2-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 | copy number gain | See cases [RCV000138962] | Chr9:193412..138159073 [GRCh38] Chr9:204104..141053525 [GRCh37] Chr9:194104..140173346 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic|conflicting data from submitters |
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 | copy number gain | See cases [RCV000141876] | Chr9:203861..138125937 [GRCh38] Chr9:203861..141020389 [GRCh37] Chr9:193861..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9q34.13-34.3(chr9:132386553-138059695)x3 | copy number gain | See cases [RCV000142636] | Chr9:132386553..138059695 [GRCh38] Chr9:135261940..140954147 [GRCh37] Chr9:134251761..140073968 [NCBI36] Chr9:9q34.13-34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 | copy number gain | See cases [RCV000143476] | Chr9:203862..138125937 [GRCh38] Chr9:203862..141020389 [GRCh37] Chr9:193862..140140210 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 | copy number gain | See cases [RCV000148113] | Chr9:193412..138179445 [GRCh38] Chr9:204193..141073897 [GRCh37] Chr9:194193..140193718 [NCBI36] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 | copy number gain | See cases [RCV000240081] | Chr9:163131..141122114 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
NM_001080483.3(MYMK):c.481G>C (p.Gly161Arg) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001270899] | Chr9:133515526 [GRCh38] Chr9:136380648 [GRCh37] Chr9:9q34.2 |
uncertain significance |
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) | copy number gain | See cases [RCV000449375] | Chr9:62525..141006407 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 | copy number gain | not specified [RCV003986800] | Chr9:203861..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q33.3-34.3(chr9:128652785-141044751)x3 | copy number gain | See cases [RCV000447080] | Chr9:128652785..141044751 [GRCh37] Chr9:9q33.3-34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203864-141020389)x3 | copy number gain | See cases [RCV000448978] | Chr9:203864..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q33.2-34.3(chr9:124642754-141146461)x3 | copy number gain | See cases [RCV000448784] | Chr9:124642754..141146461 [GRCh37] Chr9:9q33.2-34.3 |
pathogenic |
NM_001080483.3(MYMK):c.2T>A (p.Met1Lys) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV000495944] | Chr9:133524843 [GRCh38] Chr9:136389965 [GRCh37] Chr9:9q34.2 |
pathogenic |
NM_001080483.3(MYMK):c.553T>C (p.Cys185Arg) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV000495947] | Chr9:133514749 [GRCh38] Chr9:136379871 [GRCh37] Chr9:9q34.2 |
pathogenic |
NM_001080483.3(MYMK):c.298G>A (p.Gly100Ser) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV000495951]|See cases [RCV002252140] | Chr9:133518975 [GRCh38] Chr9:136384097 [GRCh37] Chr9:9q34.2 |
pathogenic|likely pathogenic |
NM_001080483.3(MYMK):c.271C>A (p.Pro91Thr) | single nucleotide variant | Carey-Fineman-Ziter syndrome 1 [RCV003147484]|Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV000495954]|MYMK-related condition [RCV003424047]|not provided [RCV001575718] | Chr9:133519002 [GRCh38] Chr9:136384124 [GRCh37] Chr9:9q34.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|no classifications from unflagged records |
NM_001080483.3(MYMK):c.461T>C (p.Ile154Thr) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV000495946] | Chr9:133515546 [GRCh38] Chr9:136380668 [GRCh37] Chr9:9q34.2 |
pathogenic |
GRCh37/hg19 9q21.11-34.3(chr9:71069743-140999928) | copy number gain | Global developmental delay [RCV000626548] | Chr9:71069743..140999928 [GRCh37] Chr9:9q21.11-34.3 |
likely pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:203862-141020389) | copy number gain | See cases [RCV000512392] | Chr9:203862..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q34.13-34.3(chr9:135377559-141213431)x1 | copy number loss | mTOR Inhibitor response [RCV000626442] | Chr9:135377559..141213431 [GRCh37] Chr9:9q34.13-34.3 |
drug response |
GRCh37/hg19 9q34.13-34.3(chr9:135105971-141020389)x3 | copy number gain | not provided [RCV000683160] | Chr9:135105971..141020389 [GRCh37] Chr9:9q34.13-34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141122247)x3 | copy number gain | not provided [RCV000748055] | Chr9:10590..141122247 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9q34.2(chr9:136310908-136452144)x1 | copy number loss | not provided [RCV000748743] | Chr9:136310908..136452144 [GRCh37] Chr9:9q34.2 |
benign |
GRCh37/hg19 9q34.2(chr9:136351927-136402067)x3 | copy number gain | not provided [RCV000748744] | Chr9:136351927..136402067 [GRCh37] Chr9:9q34.2 |
benign |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141107672)x3 | copy number gain | not provided [RCV000748053] | Chr9:10590..141107672 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:46587-141066491)x3 | copy number gain | not provided [RCV000748063] | Chr9:46587..141066491 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141114095)x2 | copy number gain | not provided [RCV000748054] | Chr9:10590..141114095 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
NM_001080483.3(MYMK):c.253C>T (p.Leu85=) | single nucleotide variant | not provided [RCV000963929] | Chr9:133519020 [GRCh38] Chr9:136384142 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.642C>T (p.Ser214=) | single nucleotide variant | not provided [RCV000982722] | Chr9:133514660 [GRCh38] Chr9:136379782 [GRCh37] Chr9:9q34.2 |
likely benign |
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020388)x3 | copy number gain | not provided [RCV000845900] | Chr9:203861..141020388 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
NM_001080483.3(MYMK):c.219G>A (p.Gly73=) | single nucleotide variant | not provided [RCV000970202] | Chr9:133520205 [GRCh38] Chr9:136385327 [GRCh37] Chr9:9q34.2 |
benign|likely benign |
NM_001080483.3(MYMK):c.480C>T (p.Phe160=) | single nucleotide variant | not provided [RCV000942341] | Chr9:133515527 [GRCh38] Chr9:136380649 [GRCh37] Chr9:9q34.2 |
likely benign |
NC_000009.11:g.(?_134379574)_(138678377_?)dup | duplication | Ehlers-Danlos syndrome, classic type [RCV000807925] | Chr9:134379574..138678377 [GRCh37] Chr9:9q34.13-34.3 |
uncertain significance |
GRCh37/hg19 9q21.11-34.3(chr9:71416475-141020389)x3 | copy number gain | not provided [RCV000847808] | Chr9:71416475..141020389 [GRCh37] Chr9:9q21.11-34.3 |
pathogenic |
NM_001080483.3(MYMK):c.165G>C (p.Leu55Phe) | single nucleotide variant | Inborn genetic diseases [RCV003240637] | Chr9:133520259 [GRCh38] Chr9:136385381 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.253C>A (p.Leu85Met) | single nucleotide variant | Inborn genetic diseases [RCV003239778] | Chr9:133519020 [GRCh38] Chr9:136384142 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.-49T>C | single nucleotide variant | not provided [RCV001688820] | Chr9:133524893 [GRCh38] Chr9:136390015 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.135+179A>G | single nucleotide variant | not provided [RCV001620131] | Chr9:133524531 [GRCh38] Chr9:136389653 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.190G>A (p.Asp64Asn) | single nucleotide variant | not provided [RCV001551885] | Chr9:133520234 [GRCh38] Chr9:136385356 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.251-18T>C | single nucleotide variant | not provided [RCV001541252] | Chr9:133519040 [GRCh38] Chr9:136384162 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.399+27C>G | single nucleotide variant | not provided [RCV001617544] | Chr9:133518847 [GRCh38] Chr9:136383969 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.267C>T (p.Asp89=) | single nucleotide variant | not provided [RCV000930226] | Chr9:133519006 [GRCh38] Chr9:136384128 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.348G>C (p.Gly116=) | single nucleotide variant | not provided [RCV000930019] | Chr9:133518925 [GRCh38] Chr9:136384047 [GRCh37] Chr9:9q34.2 |
likely benign |
NM_001080483.3(MYMK):c.615G>A (p.Pro205=) | single nucleotide variant | not provided [RCV000918491] | Chr9:133514687 [GRCh38] Chr9:136379809 [GRCh37] Chr9:9q34.2 |
benign |
NC_000009.11:g.(?_135771602)_(136769889_?)dup | duplication | Tuberous sclerosis 1 [RCV001033460] | Chr9:135771602..136769889 [GRCh37] Chr9:9q34.13-34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.468C>T (p.Pro156=) | single nucleotide variant | not provided [RCV000890513] | Chr9:133515539 [GRCh38] Chr9:136380661 [GRCh37] Chr9:9q34.2 |
likely benign |
NM_001080483.3(MYMK):c.300C>T (p.Gly100=) | single nucleotide variant | not provided [RCV000933960] | Chr9:133518973 [GRCh38] Chr9:136384095 [GRCh37] Chr9:9q34.2 |
likely benign |
NM_001080483.3(MYMK):c.517-4G>A | single nucleotide variant | not provided [RCV000890572] | Chr9:133514789 [GRCh38] Chr9:136379911 [GRCh37] Chr9:9q34.2 |
likely benign |
NC_000009.11:g.(?_135771850)_(137038881_?)dup | duplication | Tuberous sclerosis 1 [RCV001033564] | Chr9:135771850..137038881 [GRCh37] Chr9:9q34.13-34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.517-169T>G | single nucleotide variant | not provided [RCV001710286] | Chr9:133514954 [GRCh38] Chr9:136380076 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.399+361A>G | single nucleotide variant | not provided [RCV001680121] | Chr9:133518513 [GRCh38] Chr9:136383635 [GRCh37] Chr9:9q34.2 |
benign |
NC_000009.12:g.133524994T>G | single nucleotide variant | not provided [RCV001665632] | Chr9:133524994 [GRCh38] Chr9:136390116 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.517-208T>G | single nucleotide variant | not provided [RCV001611094] | Chr9:133514993 [GRCh38] Chr9:136380115 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.136-27T>C | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001838702]|not provided [RCV001611502] | Chr9:133520315 [GRCh38] Chr9:136385437 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.135+81T>G | single nucleotide variant | not provided [RCV001648472] | Chr9:133524629 [GRCh38] Chr9:136389751 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.399+5G>A | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001004946]|not provided [RCV001766821] | Chr9:133518869 [GRCh38] Chr9:136383991 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.305T>C (p.Leu102Pro) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001089958] | Chr9:133518968 [GRCh38] Chr9:136384090 [GRCh37] Chr9:9q34.2 |
likely pathogenic |
NM_001080483.3(MYMK):c.242C>T (p.Ser81Leu) | single nucleotide variant | not provided [RCV001549477] | Chr9:133520182 [GRCh38] Chr9:136385304 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.482_483insCCCA (p.Ala162fs) | insertion | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001267695] | Chr9:133515524..133515525 [GRCh38] Chr9:136380646..136380647 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.162del (p.Leu55fs) | deletion | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001333720] | Chr9:133520262 [GRCh38] Chr9:136385384 [GRCh37] Chr9:9q34.2 |
pathogenic |
NM_001080483.3(MYMK):c.535G>A (p.Val179Ile) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001332769] | Chr9:133514767 [GRCh38] Chr9:136379889 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.534T>C (p.Tyr178=) | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001838682]|not provided [RCV001537062] | Chr9:133514768 [GRCh38] Chr9:136379890 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.136-144C>T | single nucleotide variant | not provided [RCV001619287] | Chr9:133520432 [GRCh38] Chr9:136385554 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.136-43T>C | single nucleotide variant | Congenital nonprogressive myopathy with Moebius and Robin sequences [RCV001838753]|not provided [RCV001669715] | Chr9:133520331 [GRCh38] Chr9:136385453 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.250+208T>G | single nucleotide variant | not provided [RCV001681263] | Chr9:133519966 [GRCh38] Chr9:136385088 [GRCh37] Chr9:9q34.2 |
benign |
NM_001080483.3(MYMK):c.365T>C (p.Ile122Thr) | single nucleotide variant | not provided [RCV001771319] | Chr9:133518908 [GRCh38] Chr9:136384030 [GRCh37] Chr9:9q34.2 |
uncertain significance |
GRCh37/hg19 9p24.3-q34.3(chr9:353349-141020389) | copy number gain | not specified [RCV002053823] | Chr9:353349..141020389 [GRCh37] Chr9:9p24.3-q34.3 |
pathogenic |
NC_000009.11:g.(?_135139626)_(140034216_?)dup | duplication | Developmental and epileptic encephalopathy, 14 [RCV003111109]|Leigh syndrome [RCV003122287]|Rafiq syndrome [RCV003122286]|Tuberous sclerosis 1 [RCV003111108] | Chr9:135139626..140034216 [GRCh37] Chr9:9q34.13-34.3 |
uncertain significance |
NC_000009.11:g.(?_131087402)_(141016451_?)dup | duplication | Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome [RCV003119700] | Chr9:131087402..141016451 [GRCh37] Chr9:9q34.11-34.3 |
uncertain significance |
NC_000009.11:g.(?_136218768)_(141016451_?)dup | duplication | Kleefstra syndrome 1 [RCV003122719] | Chr9:136218768..141016451 [GRCh37] Chr9:9q34.2-34.3 |
uncertain significance |
NM_001080483.3(MYMK):c.8C>T (p.Thr3Met) | single nucleotide variant | Carey-Fineman-Ziter syndrome 1 [RCV003132789]|MYMK-related condition [RCV003906659] | Chr9:133524837 [GRCh38] Chr9:136389959 [GRCh37] Chr9:9q34.2 |
benign|uncertain significance |
NM_001080483.3(MYMK):c.565A>G (p.Met189Val) | single nucleotide variant | Inborn genetic diseases [RCV003262985] | Chr9:133514737 [GRCh38] Chr9:136379859 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.506T>G (p.Phe169Cys) | single nucleotide variant | Inborn genetic diseases [RCV003356250] | Chr9:133515501 [GRCh38] Chr9:136380623 [GRCh37] Chr9:9q34.2 |
uncertain significance |
GRCh37/hg19 9q34.2(chr9:136378366-136726628)x3 | copy number gain | not provided [RCV003484785] | Chr9:136378366..136726628 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.542G>A (p.Ser181Asn) | single nucleotide variant | MYMK-related condition [RCV003399973] | Chr9:133514760 [GRCh38] Chr9:136379882 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.159del (p.Gly54fs) | deletion | not provided [RCV003443271] | Chr9:133520265 [GRCh38] Chr9:136385387 [GRCh37] Chr9:9q34.2 |
uncertain significance |
NM_001080483.3(MYMK):c.243G>A (p.Ser81=) | single nucleotide variant | not provided [RCV003430375] | Chr9:133520181 [GRCh38] Chr9:136385303 [GRCh37] Chr9:9q34.2 |
likely benign |
NM_001080483.3(MYMK):c.159C>T (p.Pro53=) | single nucleotide variant | not provided [RCV003884920] | Chr9:133520265 [GRCh38] Chr9:136385387 [GRCh37] Chr9:9q34.2 |
likely benign |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
D9S1268 |
|
|||||||||||||||||||||||||
D9S1311 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | visual system | adipose tissue | appendage | entire extraembryonic component | |
High | |||||||||||||||||
Medium | 1 | 1 | 16 | 9 | 10 | 2 | 16 | ||||||||||
Low | 11 | 11 | 61 | 19 | 31 | 14 | 620 | 142 | 644 | 55 | 202 | 133 | 8 | 1 | 8 | 604 | |
Below cutoff | 565 | 767 | 857 | 233 | 396 | 192 | 1474 | 785 | 1863 | 184 | 555 | 738 | 42 | 323 | 936 | 2 |
RefSeq Transcripts | NM_001080483 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
GenBank Nucleotide | BX324209 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
CP068269 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | ENST00000339996 ⟹ ENSP00000419712 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000413714 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001080483 ⟹ NP_001073952 | ||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
Protein RefSeqs | NP_001073952 | (Get FASTA) | NCBI Sequence Viewer |
GenBank Protein | A6NI61 | (Get FASTA) | NCBI Sequence Viewer |
Ensembl Protein | ENSP00000419712 | ||
ENSP00000419712.2 |
RefSeq Acc Id: | NP_001073952 ⟸ NM_001080483 |
- UniProtKB: | A6NI61 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | ENSP00000419712 ⟸ ENST00000339996 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-A6NI61-F1-model_v2 | AlphaFold | A6NI61 | 1-221 | view protein structure |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:33778 | AgrOrtholog |
COSMIC | MYMK | COSMIC |
Ensembl Genes | ENSG00000187616 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000339996 | ENTREZGENE |
ENST00000339996.4 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000187616 | GTEx |
HGNC ID | HGNC:33778 | ENTREZGENE |
Human Proteome Map | MYMK | Human Proteome Map |
InterPro | NGX6/PGAP6/MYMK | UniProtKB/Swiss-Prot |
KEGG Report | hsa:389827 | UniProtKB/Swiss-Prot |
NCBI Gene | 389827 | ENTREZGENE |
OMIM | 615345 | OMIM |
PANTHER | POST-GPI ATTACHMENT TO PROTEINS FACTOR 6 | UniProtKB/Swiss-Prot |
PTHR14319 | UniProtKB/Swiss-Prot | |
Pfam | DUF3522 | UniProtKB/Swiss-Prot |
PharmGKB | PA165586306 | PharmGKB |
UniProt | A6NI61 | ENTREZGENE, UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2017-05-16 | MYMK | myomaker, myoblast fusion factor | TMEM8C | transmembrane protein 8C | Symbol and/or name change | 5135510 | APPROVED |